Posted 1 month ago

Safety and Efficacy of EIK1001-006 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

ClinicalTrials.gov ID NCT06697301

Protocol number EIK1001-006

Sponsor Eikon Therapeutics